Patient Guide: Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 14 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07901751
Status: 🟢 Enrolling Now
Condition: Retinitis Pigmentosa (RP), Inherited Retinal Diseases
Phase: Phase II, Phase III

Find a Study Location Near You

This study is available at 14 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Phoenix, Arizona
  • • Bakersfield, California
  • • Beverly Hills, California
  • • And 11 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT) - Join Clinical Trial NCTNCT07901751

How to Join This Clinical Trial - NCTNCT07901751

Learn how to participate in this Phase II, Phase III trial studying an investigational therapy for Retinitis Pigmentosa (RP), Inherited Retinal Diseases. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Retinitis Pigmentosa (RP), Inherited Retinal Diseases. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Retinitis Pigmentosa (RP), Inherited Retinal Diseases
Treatment Being Tested
Investigational treatment
Study Phase
Phase II, Phase III - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07901751 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 14 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85020 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Bakersfield, California 93309 - United States

Status: RECRUITING

Clinical Research Site

Beverly Hills, California 90211 - United States

Status: RECRUITING

Clinical Research Site

Santa Barbara, California 93103 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Deerfield Beach, Florida 33064 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

‘Aiea, Hawaii 96701 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Oak Park, Illinois 60304 - United States

Status: RECRUITING

Clinical Research Site

Detroit, Michigan 48201 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Edina, Minnesota 55435 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Bloomfield, New Jersey 07003 - United States

Status: NOT_YET_RECRUITING

And 4 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Phase II, Phase III clinical trial for Retinitis Pigmentosa (RP), Inherited Retinal Diseases:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation